{'fraction_non_alphanumeric': 0.020134228187919462, 'fraction_numerical': 0.010738255033557046, 'mean_word_length': 5.26890756302521, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Nonsurgical treatment of pelvic rhabdomyosarcoma: A case report

A 2 ½‐year‐old male child with rhabdomyosarcoma of the prostate was treated with radiation to the pelvis, consisting of 5,600 rads in 7 ½ weeks, and combination chemotherapy of Vincristine and Actinomycin D. Surgery had been refused. The child is alive and disease‐free more than 5 years after diagnosis, and over 2 years following the cessation of all therapy. Recent advances in radiotherapy and adjuvant chemotherapy have significantly improved the outlook in this aggressive childhood neoplasm and have made a less aggressive and less mutilating surgical approach often desirable. This, in turn, holds out the prospect of improved quality of survival in children so afflicted.